Intended for healthcare professionals

  1. Cancer—A Biological...
  2. Cancer—A Biological Approach
Articles

Cancer—A Biological Approach

Br Med J 1957; 1 doi: https://doi.org/10.1136/bmj.1.5022.779 (Published 06 April 1957) Cite this as: Br Med J 1957;1:779

Related articles

  • No related articles found.

See more

Cited by...

  • Exploiting Tumor Neoantigens to Target Cancer Evolution: Current Challenges and Promising Therapeutic Approaches
  • Cancer-Induced Immunosuppression can enable Effectiveness of Immunotherapy through Bistability Generation: a mathematical and computational Examination
  • Tissue-autonomous immune response regulates stress signalling during hypertrophy
  • Two-zone tumor tolerance can arise from a simple immunological feedforward motif that estimates tumor growth rates
  • From Cancer Immune Surveillance to Cancer Immunoediting: Birth of Modern Immuno-Oncology
  • Immunoediting is not a primary transformation event in a murine model of MLL-ENL AML
  • Masterful Antibodies: Checkpoint Blockade
  • The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy
  • The promise of immunotherapy in head and neck squamous cell carcinoma: combinatorial immunotherapy approaches
  • Cutting Edge: IgE Plays an Active Role in Tumor Immunosurveillance in Mice
  • Mutational Landscape and Sensitivity to Immune Checkpoint Blockers
  • IgG Glycome in Colorectal Cancer
  • How Cancers Escape Immune Destruction and Mechanisms of Action for the New Significantly Active Immune Therapies: Helping Nonimmunologists Decipher Recent Advances
  • POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
  • The Path to Reactivation of Antitumor Immunity and Checkpoint Immunotherapy
  • CD4+ T Lymphocyte Ablation Prevents Pancreatic Carcinogenesis in Mice
  • Rational combinations of immunotherapeutics that target discrete pathways
  • Translating Tumor Antigens into Cancer Vaccines
  • Vaccine Prevention of Cancer: Can Endogenous Antigens Be Targeted?
  • Decreased Tumor Surveillance after Adoptive T-Cell Therapy
  • Active Induction of Tumor-Specific IgE Antibodies by Oral Mimotope Vaccination
Back to top